Axsome Therapeutics, Inc. share price logo

Axsome Therapeutics, Inc. Share Price

NASDAQ: AXSM

Mid Cap

$118.42

-4.54

(-3.70%)

as on

Axsome Therapeutics, Inc. Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $117.75
    $123.04
    downward going graph

    0.57%

    Downside

    3.90%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $75.56
    $139.13
    downward going graph

    36.19%

    Downside

    17.49%

    Upside

    downward going graph

Axsome Therapeutics, Inc. share price movements today

Previous Close
$122.96
Open
$122.65
Volume
574.2K
Day's Low - High
$117.75 - $123.04
52 Week Low - High
$75.56 - $139.13

Axsome Therapeutics, Inc. Historical Returns

1 Month Return
+ 12.41 %
3 Month Return
+ 18.12 %
1 Year Return
+ 31.27 %
3 Year Return
+ 101.74 %
5 Year Return
+ 68.37 %

Axsome Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Axsome Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.1B

EPS (TTM)

-3.6287

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-13.72

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

0

EBITDA

-199.6M

Revenue (TTM)

495.0M

Profit Margin

-49.88%

Return On Equity TTM

2114800.00%

Axsome Therapeutics, Inc. Stock Valuation

Track how Axsome Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Axsome Therapeutics, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 13, 2025

Today (-13.72x)

September 13, 2025

Industry (10.13x)

September 13, 2025

Highest (0.00x)

September 13, 2025

LowHigh

Today’s Price to Earnings Ratio: -13.72x

Axsome Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Axsome Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$6.1B68.37%-13.72-49.88%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Axsome Therapeutics, Inc. Stock including INR - Dollar returns

The Axsome Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Axsome Therapeutics, Inc. investment value today

Current value as on today

₹1,31,562

Returns

₹31,562

(+31.56%)

Returns from Axsome Therapeutics, Inc. Stock

₹26,423 (+26.42%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Axsome Therapeutics, Inc. Stock

Based on 22 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 22 analysts, 90.91% of analysts recommend a 'BUY' rating for Axsome Therapeutics, Inc.. Average target price of $176.84

Axsome Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Axsome Therapeutics, Inc..

What analysts predicted

33.04%UPSIDE

Target Price

$176.84

Current Price

$118.42

Analyzed by

22 Analysts

Target

$176.84

Axsome Therapeutics, Inc. target price $176.84, a slight upside of 33.04% compared to current price of $118.42. According to 22 analysts rating.

Axsome Therapeutics, Inc. Stock's Interest Amongst Investors

Search interest for Axsome Therapeutics, Inc. Stock has increased by 90% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:90% versus previous 30 day period

Axsome Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
94
46
57
71
74
87
104
118
121
150
Gross Profit
87
42
51
64
66
79
96
108
111
136
Operating Income
-6
-65
-62
-98
-68
-78
-62
-72
-56
-36
EBITDA
-4
-62
-60
-96
-65
-78
-60
-70
-56
-36
Interest Expense
2
2
0
0
1
1
1
6
2
1
Depreciation
1
1
1
1
1
1
2
2
2
2
Income Before Tax
-8
-67
-62
-98
-68
-79
-64
-74
-59
-48
Income Tax Expense
2
0
0
-3
0
-
-
0
-
0
Net Income
-11
-67
-62
-98
-68
-79
-64
-74
-59
-47
Net Profit Margin
-11.86%
-143.83%
-107.62%
-137.92%
-91.14%
-91.03%
-61.67%
-63.08%
-48.91%
-31.97%

Axsome Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
8
50
270
385
Gross Profit
0
0
0
0
0
0
-1
44
244
352
Operating Income
-9
-27
-27
-32
-67
-99
-124
-176
-231
-280
EBITDA
-9
-27
-27
-32
-67
-99
-123
-174
-224
-272
Interest Expense
0
0
1
1
1
2
5
7
6
6
Depreciation
-
-
0
0
0
0
1
4
6
7
Income Before Tax
-10
-27
-28
-30
-68
-102
-130
-187
-238
-287
Income Tax Expense
1
0
1
3
1
2
4
10
0
0
Net Income
-10
-27
-28
-30
-69
-105
-134
-197
-239
-287
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-1530.01%
-395.24%
-88.41%
-74.47%

Axsome Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-67
-62
-98
-68
-79
-64
-74
-59
-47
Operating Cash Flow
-55
-53
-30
-53
-30
-18
-26
-43
-32
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
246
33
0
-1
14
30
14
29
34
Change in Cash
190
-20
-30
-54
-15
11
-11
-14
2

Axsome Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-27
-28
-30
-68
-102
-130
-187
-239
-287
Operating Cash Flow
-21
-26
-30
-46
-78
-108
-116
-145
-128
Investing Cash Flow
0
0
0
0
0
0
-53
0
0
Financing Cash Flow
9
23
10
252
42
11
284
331
57
Change in Cash
-11
-2
-20
205
-36
-97
114
185
-70

Global Institutional Holdings in Axsome Therapeutics, Inc.

Funds
Holdings
Vanguard Group Inc
7.87%
BlackRock Inc
7.16%
RTW INVESTMENTS, LLC
5.94%
Bvf Inc
3.43%
FMR Inc
2.53%

Insights on Axsome Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 9 quarters, 46.7M → 150.04M (in $), with an average increase of 13.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -74.91M → -47.97M (in $), with an average increase of 25.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 31.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 49.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AXSM stock has moved down by -8.4%

About Axsome Therapeutics, Inc.

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.
OrganisationAxsome Therapeutics, Inc.
HeadquartersOne World Trade Center, New York, NY, United States, 10007
IndustryHealth Technology
CEODr. Herriot Tabuteau M.D.
E-voting on sharesClick here to vote

Key Management of Axsome Therapeutics, Inc.

Name

Title

Mr. Hunter Murdock Esq.

General Counsel & Secretary

Mr. Ari Maizel

Chief Commercial Officer

Darren Opland

Director of Corporate Communications

Dr. Herriot Tabuteau M.D.

Founder, Chairman, CEO & President

Mr. Nick Pizzie CPA, M.B.A.

Chief Financial Officer

Mr. Mark L. Jacobson M.A.

Chief Operating Officer

FAQs

What is Axsome Therapeutics, Inc. share price today?

Axsome Therapeutics, Inc. share price today is $118.42 as on at the close of the market. Axsome Therapeutics, Inc. share today touched a day high of $123.04 and a low of $117.75.

What is the 52 week high and 52 week low for Axsome Therapeutics, Inc. share?

Axsome Therapeutics, Inc. share touched a 52 week high of $139.13 on and a 52 week low of $75.56 on . Axsome Therapeutics, Inc. stock price today i.e. is closed at $118.42,which is 14.89% down from its 52 week high and 56.72% up from its 52 week low.

What is Axsome Therapeutics, Inc.'s market capitalisation today?

Axsome Therapeutics, Inc. market capitalisation is $0.01T as on .

How to invest in Axsome Therapeutics, Inc. Stock (AXSM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Axsome Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Axsome Therapeutics, Inc. Shares that will get you 0.0127 shares as per Axsome Therapeutics, Inc. share price of $118.42 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Axsome Therapeutics, Inc. Stock (AXSM) from India?

Indian investors can start investing in Axsome Therapeutics, Inc. (AXSM) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Axsome Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Axsome Therapeutics, Inc. share’s latest price of $118.42 as on September 13, 2025 at 1:29 am IST, you will get 0.0844 shares of Axsome Therapeutics, Inc.. Learn more about fractional shares .

What are the returns that Axsome Therapeutics, Inc. has given to Indian investors in the last 5 years?

Axsome Therapeutics, Inc. stock has given 68.37% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?